Biomanufacturing Scale Up

Materials Innovator AlgiKnit Closes $13 Million Series A To Transform the Textile Industry's Environmental Impact

Jun 29, 2022

AlgiKnit Closes $13 Million Series A To Scale Production To Meet Global Demand.

View All

Engineered Human Therapies

Environment

Food Agriculture

Biomanufacturing Scale Up

Bio Design

Ai Digital Biology

Aaron Blotnick

Sep 15, 2026

One Model, Every Microbiome

Capital Markets

Biopharma Solutions Tools Tech

Sep 15, 2026

Bitrobius Genetics and the University of Cambridge secure a £700k ARIA grant to develop mitochondrial gene delivery technologies

Biopharma Solutions Tools Tech

Sep 15, 2026

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

Capital Markets

Engineered Human Therapies

Sep 15, 2026

Ride Therapeutics Announces up to US$7.3 Million Investment from the Cystic Fibrosis Foundation to Advance Next-Generation Genetic Medicines

Biomanufacturing Scale Up

Engineered Human Therapies

Biopharma Solutions Tools Tech

Sep 15, 2026

Partillion Bioscience Secures $2.1 Million NIH SBIR Grant to Advance Large-Scale Cell-Cell Interaction Sequencing

Engineered Human Therapies

Biopharma Solutions Tools Tech

Sep 15, 2026

TwoStep Therapeutics Announces Oversubscribed $62.5 Million Series A Financing and FDA Clearance of IND for First-in-Class Peptide-Drug Conjugate

Engineered Human Therapies

Environment

Food Agriculture

Biomanufacturing Scale Up

Bio Design

Ai Digital Biology

Aaron Blotnick

Sep 15, 2026

One Model, Every Microbiome

Capital Markets

Biopharma Solutions Tools Tech

Sep 15, 2026

Bitrobius Genetics and the University of Cambridge secure a £700k ARIA grant to develop mitochondrial gene delivery technologies

Biopharma Solutions Tools Tech

Sep 15, 2026

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

Capital Markets

Engineered Human Therapies

Sep 15, 2026

Ride Therapeutics Announces up to US$7.3 Million Investment from the Cystic Fibrosis Foundation to Advance Next-Generation Genetic Medicines

Newletter & More

SynBioBeta

2027

May 3-6,

2027

San Jose Convention Center ·

CA, USA

Event Details

Join List

Materials Innovator AlgiKnit Closes $13 Million Series A To Transform the Textile Industry's Environmental Impact

Read More

One Model, Every Microbiome

Bitrobius Genetics and the University of Cambridge secure a £700k ARIA grant to develop mitochondrial gene delivery technologies

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

Ride Therapeutics Announces up to US$7.3 Million Investment from the Cystic Fibrosis Foundation to Advance Next-Generation Genetic Medicines

Partillion Bioscience Secures $2.1 Million NIH SBIR Grant to Advance Large-Scale Cell-Cell Interaction Sequencing

TwoStep Therapeutics Announces Oversubscribed $62.5 Million Series A Financing and FDA Clearance of IND for First-in-Class Peptide-Drug Conjugate

One Model, Every Microbiome

Bitrobius Genetics and the University of Cambridge secure a £700k ARIA grant to develop mitochondrial gene delivery technologies

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

Ride Therapeutics Announces up to US$7.3 Million Investment from the Cystic Fibrosis Foundation to Advance Next-Generation Genetic Medicines

Newletter & More

Newsletter

Newsletter

Newsletter

SynBioBeta 2027

Categories

Company

Newsletter

SynBioBeta 2027

Categories

Company

Newsletter

SynBioBeta 2027

Categories

Company